Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 14, 2024
[ Wed, Feb 14th 2024
] - WOPRAI
Tue, February 13, 2024
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
[ Tue, Feb 13th 2024
] - WOPRAI
Paul Knight Maintained (WST) at Buy with Increased Target to $470 on, Feb 13th, 2024
Paul Knight of Keybanc, Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Increased Target from $440 to $470 on, Feb 13th, 2024.
Paul has made no other calls on WST in the last 4 months.
There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, 0 agree with Paul's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Paul
- David Windley of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $536 on, Wednesday, February 7th, 2024
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $390 on, Friday, October 27th, 2023
